Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia–but for patients, on GLP-1’s there may still be ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...

We need to work towards ensuring that they don’t have a second event. And that’s more towards prevention, the ambulatory ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

this could cause complications. So the FDA is warning patients about this, and says they should tell their doctor if they are taking Ozempic or any of these drugs before undergoing a surgery or ...